• Changes in FDA, Cannabis Policies and AI Developments

  • May 13 2024
  • Length: 27 mins
  • Podcast

Changes in FDA, Cannabis Policies and AI Developments

Listen for free

View show details

  • Summary

  • In the latest episode of Holland & Knight's Public Policy & Regulation Group "Eyes on Washington" podcast series, Healthcare & Life Sciences attorneys Michael Werner and Sara Klock examine pivotal shifts in U.S. Food and Drug Administration (FDA) regulations.

    This episode explores updates in three crucial areas: the regulation of laboratory developed tests (LDTs), the proposed reclassifying of cannabis to a Schedule III drug by the U.S. Drug Enforcement Administration (DEA) and the FDA's evolving approach to artificial intelligence (AI). It also covers the FDA's revised guidance on new dietary ingredient notifications (NDINs) for dietary supplements. The discussion provides a comprehensive overview of these significant regulatory updates, breaking down potential impacts and exploring opportunities for industry engagement in influencing upcoming changes.
    Show More Show Less
Show More Show Less

What listeners say about Changes in FDA, Cannabis Policies and AI Developments

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available